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Summary. Gastrointestinal symptoms in diabetic 
patients are commonplace, and are believed to be due, at 
least partly, to neuropathy of the gut. In the present 
study, therefore, some important neurotransmitters in the 
myenteric plexus were investigated in non-obese 
diabetic mice, an animal model of human type 1 
diabetes. For this purpose, immunocytochemistry was 
applied on sections from antrum, duodenum and colon, 
subsequently quantified by computerized image analysis. 
Whereas the number of vasoactive intestinal peptide 
(VIP)-positive neurons was increased in antral myenteric 
ganglia of diabetic mice, there was a decreased density 
of nerve fibres in muscularis propria. No difference was 
seen in the VIP of duodenum and colon. Acetylcholine- 
containing nerve fibres showed an increased volume 
density in muscularis propria of antrum and duodenum, 
but a decreased density in colon of diabetic mice, as 
compared with controls. There was a decreased number 
of neurons containing nitric oxide synthase (NOS) in 
myenteric ganglia of antrum and duodenum. No 
difference was seen in density of NOS-containing nerve 
fibres in muscularis propria. There was no difference 
regarding neuropeptide Y (NPY) and galanin between 
diabetic and control mice; nor was there any difference 
between pre-diabetic NOD mice and controls regarding 
all bioactive substances investigated. It is concluded that 
the diabetic state affects the innervation of gut in this 
animal model. The present findings may be of some 
relevance to the gastrointestinal symptoms seen in 
patients with diabetes. 
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Introduction 
Neuropathy is a common complication of diabetes 
mellitus, occurring in both the central and peripheral 
nervous system (Dyck et al., 1993; Locke 111, 1995). The 
gastrointestinal tract is richly innervated with nerves of 
extrinsic (central nervous system) and of intrinsic origin 
(enteric nervous system) (Ekblad et al., 1991). These 
systems are of importance in the regulation of gut 
functions such as motility, secretion and absorption 
(Allescher, 1991; Rangachari, 1991; Costa and Brookes, 
1994). In diabetes, up to 76% of the patients suffer from 
clinical symptoms emanating from the gastrointestinal 
tract, such as nausea, vomiting, heartburn, constipation, 
diarrhoea and faecal incontinence (Bargen et al., 1936; 
Kassander, 1958; Feldman and Schiller, 1983; Locke 111, 
1995). It is possible that neuropathy of the gut is 
involved in the pathogenesis of these symptoms. 
Unfortunately innervation of the gut is difficult to study 
in patients with diabetes, as transmural biopsies are 
needed. In order to investigate a possible disturbance in 
the diabetic state, we must therefore use animal models. 
Several studies made in chemically-induced diabetic rats 
as well as in genetically diabetic mice (Schmidt et al., 
1981; Belai et al., 1985; Ballman and Conlon, 1985; 
Loesch et al., 1986; DiGiulio et al., 1989; Belai et al., 
1991; Wrzos et al., 1997; El-Salhy and SplngCus, 
1998a,b; Spingtus and El-Salhy, 1998a) have revealed 
both ultrastructural and biochemical abnormalities in 
sympathetic and parasympathetic innervation of the gut, 
as well as in certain neurotransmitters in the enteric 
nervous system. However, several important neuro- 
transmitters had not hitherto been studied systematically. 
The aim of the present study therefore was to 
investigate important neurotransmitters, such as VIP, 
NPY, galanin, acetylcholine, adrenaline and NO, in the 
gastrointestinal myenteric plexus of an animal model of 
human type 1 diabetes, namely the non-obese diabetic 
(NOD) mouse (Makino et a l . ,  1980;  Kolb, 1987; 
Tochino, 1987). 
Material and methods 
Animals 
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Female pre-diabetic and diabetic non-obese diabetic 
(NOD) mice, aged 22-24 weeks, were investigated. 
Control animals were non-diabetic age and sex matched 





